Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine vs sufentanil in epidural labor analgesia for gestational diabetes mellitus
ChiCTR2400080060Phase 3Not yet recruiting
- Sponsor
- Jinan Maternal and Child Care Hospital
- Start
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of dexmedetomidine in gestational diabetes mellitus (GDM) (2 arms), sponsored by Jinan Maternal and Child Care Hospital. Primary endpoint: plasma glucose-coefficient of variation during delivery. Planned start Jan 2024; status: not yet recruiting.
02
Drugs
dexmedetomidine
03
Conditions
gestational diabetes mellitus (GDM)
Beyond the preview
Go deeper on ChiCTR2400080060.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400080060.